Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine

ClinicalTrials.gov ID: NCT03488563

Public ClinicalTrials.gov record NCT03488563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 9:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, randomized, vehicle-controlled, double-blind, multi-center study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray for preventive treatment in subjects with episodic migraine.

Study identification

NCT ID
NCT03488563
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AOBiome LLC
Industry
Enrollment
313 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2018 (Actual)
Primary completion
Jun 17, 2019 (Actual)
Completion
Jul 16, 2019 (Actual)
Last update posted
Oct 4, 2022

2018 – 2019

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Baptist Health Center for Clinical Research Little Rock Arkansas 72205 —
Collaborative Neuroscience Network, LLC Long Beach California 90806 —
CI Trials Riverside California 92506 —
Neurological Research Institute Santa Monica California 90404 —
New England Institute for Neurology and Headache (NEINH)/Medical Practice Stamford Connecticut 06905 —
Clinical Neuroscience Solution, Inc Jacksonville Florida 32256 —
Precision Clinical Research Lauderdale Lakes Florida 33319 —
Clinical Neuroscience Solution, Inc Orlando Florida 32801 —
Palm Beach Research West Palm Beach Florida 33409 —
Neurostudies Clinical Research Decatur Georgia 30033 —
BTC of New Bedford New Bedford Massachusetts 02740 —
MedVadis Research Watertown Massachusetts 02472 —
Altea Research Institute Las Vegas Nevada 89102 —
Rochester Clinical Research INC Rochester New York 14609 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Coastal Carolina Research Center North Charleston South Carolina 29406 —
Clinical Neuroscience Solution, Inc Memphis Tennessee 38119 —
FutureSearch Trials of Neurology and Sleep Lab, L.P. Austin Texas 78731 —
FutureSearch Trials of Dallas, L.P. Dallas Texas 75231 —
Texas Center for Drug Development Houston Texas 77081 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03488563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 4, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03488563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →